REG - Haleon PLC - Director/PDMR Shareholding

HALEONAnnouncement

11/04/2025 10:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250411:nRSK7015Ea&default-theme=true

RNS Number : 7015E  Haleon PLC  11 April 2025

 

Haleon plc: Director/PDMR Shareholding

 

11 April 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today
announces notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by Persons
Discharging Managerial Responsibilities ("PDMRs").

 

 1       Details of the person discharging managerial responsibilities / person closely

       associated

 a)      Name                                                             Adrian Morris

 2       Reason for the notification

 a)      Position/status                                                  General Counsel - PDMR

 b)      Initial notification /Amendment                                  Initial Notification

 3       Details of the issuer, emission allowance market participant, auction

       platform, auctioneer or auction monitor

 a)      Name                                                             Haleon plc

 b)      LEI                                                              549300PSB3WWEODCUP19

 4       Details of the transaction(s): section to be repeated for (i) each type of

       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
         place where transactions have been conducted

 a)      Description of the financial instrument, type of instrument      Ordinary Shares of £0.01 each

         Identification code                                              GB00BMX86B70

 b)      Nature of the transaction                                        Acquisition of Partnership Shares and award of Matching Shares under the

                                                                Company's Share Reward Plan

 c)      Price(s) and volume(s)

                                                                                               Price(s)             Volume(s)
                                                                                               £3.5941              35
                                                                                               £Nil                 35 (Matching Shares)

 d)      Aggregated information

         - Aggregated volume                                              70

         - Price

 e)      Date of the transaction                                          9 April 2025

 f)      Place of the transaction                                         London Stock Exchange (XLON)

 

 

 1       Details of the person discharging managerial responsibilities / person closely

       associated

 a)      Name                                                             Tamara Rogers

 2       Reason for the notification

 a)      Position/status                                                  Chief Marketing Officer - PDMR

 b)      Initial notification /Amendment                                  Initial Notification

 3       Details of the issuer, emission allowance market participant, auction

       platform, auctioneer or auction monitor

 a)      Name                                                             Haleon plc

 b)      LEI                                                              549300PSB3WWEODCUP19

 4       Details of the transaction(s): section to be repeated for (i) each type of

       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
         place where transactions have been conducted

 a)      Description of the financial instrument, type of instrument      Ordinary Shares of £0.01 each

         Identification code                                              GB00BMX86B70

 b)      Nature of the transaction                                        Acquisition of Partnership Shares and award of Matching Shares under the

                                                                Company's Share Reward Plan

 c)      Price(s) and volume(s)

                                                                                               Price(s)             Volume(s)
                                                                                               £3.5941              35
                                                                                               £Nil                 35 (Matching Shares)

 d)      Aggregated information

         - Aggregated volume                                              70

         - Price

 e)      Date of the transaction                                          9 April 2025

 f)      Place of the transaction                                         London Stock Exchange (XLON)

 

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans five major categories - Oral Health, Pain Relief, Respiratory Health,
Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu,
Otrivin, Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHGIGDSBXBDGUB